Drug intelligence / Profile preview

duyiwei

Development stage
Unknown
Lead developer
Gansu Duyiwei Pharmaceutical
Modality
Small Molecules, Peptides
Administration
Oral, Topical
01

Overview

Duyiwei refers to a traditional Chinese herbal medicine derived from the plant Lamiophlomis rotata. It is widely used in China as an orally available Tibetan analgesic and is formulated in various dosage forms such as capsules and cataplasms. The primary active constituent identified is shanzhiside methylester (SM), an iridoid glycoside that acts as a small molecule agonist of the glucagon-like peptide-1 (GLP-1) receptor. Mechanistically, SM reduces neuropathic pain by activating spinal GLP-1 receptors, which stimulates microglial β-endorphin expression via p38 mitogen-activated protein kinase (MAPK) signaling pathways. This cascade results in analgesic and anti-inflammatory effects without inducing tolerance or cross-tolerance with opioids like morphine or β-endorphin. Clinically, Duyiwei has been approved for use in China for indications such as hemorrhage and uterine hemorrhage; it has also been studied for knee osteoarthritis and gingivitis[2][3][5].

Brand names
Duyiwei CapsuleDuyiwei Cataplasm
Other names
Lamiophlomis rotataTibetan analgesic herbDYWC
02

Targets

MAPK14 (p38 mitogen-activated protein kinase alpha)GLP1R (GLP-1R)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on duyiwei.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on duyiwei.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call